migraine disorders/headache

FIELD OF THE INVENTION A method and system for addressing the avoidance of migraines, cluster headaches, and dizziness by adjusting an individual's microbiome, and in particular to the provision of beneficial oral and gut microbes at particular times to enhance a person's health. BACKGROUND OF THE

Trauma has been documented to increase frequency of migraine headache and is a risk factor for conversion from episodic to chronic migraine. Anxiety and depression are more often associated with chronic migraine than episodic migraine, while trauma may be implicated in initiating or worsening

FIELD OF THE INVENTION The present invention relates to a method for inhibiting onset of or treating migraine headaches by administering a thromboxane A.sub.2 receptor antagonist which is a 7-oxabicyclo prostaglandin analog. BACKGROUND OF THE INVENTION European patent application No. 137,426 (Bayer

BACKGROUND OF THE INVENTION The field of the present invention relates to the delivery of energy impulses (and/or fields) to bodily tissues for therapeutic purposes. It relates more specifically to the use of non-invasive devices, such as electrical nerve stimulation devices and magnetic stimulation

BACKGROUND OF THE INVENTION The present invention relates to a new method for the treatment of migraine, tension-type headaches, atypical facial pain, post-traumatic headache, cervical pain and muscle spasm. In accordance with the invention, the method of treatment for these headaches, atypical

FIELD OF THE INVENTION The present invention relates to a composition and method for the cure of recurring migraine headaches. In particular, the composition and method involves the administration of a combination of dexamethasone, lidocaine, and thiamine to a patient. BACKGROUND OF THE

FIELD OF THE INVENTION The present invention relates to a composition and method for the cure of recurring migraine headaches. In particular, the composition and method involves the administration of a combination of dexamethasone, lidocaine, and thiamine to a patient. BACKGROUND OF THE

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to methods of treating individuals suffering from a variety of conditions wherein inhibiting reuptake of norepinephrine provides a benefit. In particular, the present invention relates to methods of treatment

BACKGROUND OF THE INVENTION This invention relates to the treatment of migraine headaches and more particularly to the use of scopolamine when administered in a transdermal therapeutic system which is programmed to deliver a measured quantity of scopolamine over a predetermined period of

FIELD OF THE INVENTION This invention relates to a method of treatment of migraine headaches. More particularly, it relates to the treatment of stress-induced migraine headaches with agents that inhibit the action or actions of the neuroendocrine polypeptide, corticotropin releasing

FIELD OF THE INVENTION This invention is directed to a method for use of a carbamate compound in preventing or treating neuropathic pain and cluster and migraine headache-associated pain. More particularly, this invention is directed to a method for use of a halogenated 2-phenyl-1,2-ethanediol

Trauma has been documented to increase frequency of migraine headache and is a risk factor for conversion from episodic to chronic migraine. Anxiety and depression are more often associated with chronic migraine than episodic migraine, while trauma may be implicated in initiating or worsening

BACKGROUND OF THE INVENTION The field of the present invention relates to the delivery of energy impulses (and/or fields) to bodily tissues for therapeutic purposes. It relates more specifically to the use of non-invasive devices, especially non-invasive electrical nerve stimulation devices and

BACKGROUND OF THE INVENTION The field of the present invention relates to the delivery of energy impulses (and/or fields) to bodily tissues for therapeutic purposes. It relates more specifically to the use of non-invasive devices, especially non-invasive electrical nerve stimulation devices and

BACKGROUND OF THE INVENTION The field of the present invention relates to the delivery of energy impulses (and/or fields) to bodily tissues for therapeutic purposes. It relates more specifically to the use of non-invasive devices, especially non-invasive electrical nerve stimulation devices and